Sort
21,281 grants matching “influenza”
STRENGTHENING SURVEILLANCE & RESPONSE TO SEASONAL INFLUENZA IN EASTERN MEDITERRAN
$1,385,380Hassan El-Mahdi El-Bushra · World Hlth Org- -E Mediterranean Office · U51 · FY2011 · IP
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)
$1,382,616Richard Rothman · Johns Hopkins University · N01 · FY2018 · AI
CAP: Pandemic Influenza Translational Research and Novel Drug Therapy
$1,382,530Jeffery Taubenberger · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Adjuvant Comparison and Characterization in Influenza , Chlamydia muridarum, and Coxiella burnetii Vaccines
$1,381,776Philip Felgner · University Of California-Irvine · N01 · FY2022 · AI
Engineering durable immunity by optimizing HIV vaccine parameters to drive long-lived plasma cell development
$1,379,954Bryan Briney · Scripps Research Institute, The · R01 · FY2025 · AI
Human Mab Cocktails to Prevent & Treat H5N1 Avian Influenza
$1,378,013Wayne A. Marasco · Dana-Farber Cancer Inst · U01 · FY2008 · AI
Innovations in Functional B Cell Epitope Discovery for Influenza
$1,377,504Garnett Kelsoe · Duke University · N01 · FY2025 · AI
Enabling risk-based testing through characterization of environmentally induced immune dysregulation and susceptibility to the SARS-CoV2 virus and COVID-19
$1,377,353Florence Burleson · · N01 · FY2024 · ES
Virus-Like Particle Vaccines for Pandemic Influenza
$1,376,620Ted M Ross · University Of Pittsburgh At Pittsburgh · U01 · FY2008 · AI
When are in-person HIV services worth the risk of COVID-19 and other communicable illnesses? Optimizing choices when virtual services are less effective
$1,375,435Anna Bershteyn · New York University School Of Medicine · RF1 · FY2025 · MH
Macque
$1,374,835Francois J Villinger · Emory University · U19 · FY2014 · AI
Vaccine and Treatment Evaluation Unit: Consultation and Testing of Cytokine Levels and Cell Activation in Clinical Samples
$1,374,317Marcelo Sztein · University Of Maryland Baltimore · N01 · FY2020 · AI
Influenza Viral Pathogenesis
$1,373,391Jeffery Taubenberger · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Analysis of Host-Pathogen Interactions
$1,372,656Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Microarrays and Macaque Influenza Model
$1,371,685Mount Sinai School Of Medicine Of Nyu · P01 · FY2004 · AI
MULTISITE EPIDEMIOLOGICAL AND VIROLOGICAL MONITORING OF INFLUENZA VIRUS SURVEILLA
$1,371,439Devendra Tarachand Mourya · Indian Council Of Medical Research · U51 · FY2009 · IP
EVASION OF HOST IMMUNE RESPONSE BY INFLUENZA VIRUS
$1,370,577Mount Sinai School Of Medicine Of Nyu · P01 · FY2002 · AI
Mechanisms Of Humoral Evasion
$1,369,871Tongqing Zhou · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Mechanisms Of Humoral Evasion
$1,369,870Peter D Kwong · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
DNA Vaccine for Seasonal & Pandemic Influenza
$1,369,470Deborah L. Fuller · University Of Washington · U01 · FY2011 · AI
Section on High Resolution Optical Imaging
$1,368,677Hari Shroff · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2015 · EB
Immunosenescence Studies of Acute Radiation Exposure in Atomic Bomb Survivors
$1,368,389Kei Nakachi · U.S. Department Of Energy--Radiation Eff · N01 · FY2011 · AI
Antibody Neutralization Mechanisms
$1,366,331Tongqing Zhou · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
A Disease-Modifying Protein Therapeutic for the Treatment of COPD
$1,364,498Christopher Lucas Prince · Verra Therapeutics, Inc. · R44 · FY2023 · HL
Human Respiratory Syncytial Virus Biology And Vaccine Development
$1,364,152Peter Leon Collins · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI